{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:15:51Z","timestamp":1791090951077,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.4065\/84.8.702","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T17:27:42Z","timestamp":1249061262000},"page":"702-706","source":"Crossref","is-referenced-by-count":34,"title":["Botulinum A Toxin\/Dimethyl Sulfoxide Bladder Instillations for Women With Refractory Idiopathic Detrusor Overactivity: A Phase 1\/2 Study"],"prefix":"10.4065","volume":"84","author":[{"given":"Steven P.","family":"Petrou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Metz-Kudashick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.4065\/84.8.702_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2007.06575.x","article-title":"Botulinum toxin A in the overactive bladder: current status and future directions","volume":"99","author":"Dmochowski","year":"2007","journal-title":"BJU Int"},{"issue":"4","key":"10.4065\/84.8.702_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ucl.2006.06.010","article-title":"The case for bladder botulinum toxin application","volume":"33","author":"Kim","year":"2006","journal-title":"Urol Clin North Am"},{"issue":"3","key":"10.4065\/84.8.702_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1520-6777(2000)19:2<127::AID-NAU3>3.0.CO;2-K","article-title":"A simplified urinary incontinence score for the evaluation of treatment outcomes","volume":"19","author":"Groutz","year":"2000","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.4065\/84.8.702_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.ju.0000165461.38088.7b","article-title":"A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials","volume":"174","author":"Nixon","year":"2005","journal-title":"J Urol"},{"issue":"2","key":"10.4065\/84.8.702_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/nau.1930140206","article-title":"Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory","volume":"14","author":"Uebersax","year":"1995","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"10.4065\/84.8.702_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refactory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"issue":"5","key":"10.4065\/84.8.702_bib7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.4065\/84.8.702_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholenergics","volume":"176","author":"Schmid","year":"2006","journal-title":"J Urol"},{"issue":"5","key":"10.4065\/84.8.702_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11934-004-0088-5","article-title":"Urologic applications of botulinum toxin therapy for voiding dysfunction","volume":"5","author":"Rackley","year":"2004","journal-title":"Curr Urol Rep"},{"issue":"2","key":"10.4065\/84.8.702_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","article-title":"Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation","volume":"173","author":"Vemulakonda","year":"2005","journal-title":"J Urol"},{"issue":"1\u20132","key":"10.4065\/84.8.702_bib11","first-page":"1","article-title":"Medical use of dimethyl sulfoxide (DMSO)","volume":"5","author":"Swanson","year":"1985","journal-title":"Rev Clin Basic Pharm"},{"issue":"3","key":"10.4065\/84.8.702_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0090-4295(78)90118-8","article-title":"Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders","volume":"11","author":"Shirley","year":"1978","journal-title":"Urology"},{"issue":"8","key":"10.4065\/84.8.702_bib13","first-page":"570","article-title":"The effect of Dimethyl Sulfoxide on the uptake of cisplatin from the urinary bladder of the dog: a pilot study","volume":"82","author":"Schoenfeld","year":"1983","journal-title":"J Am Osteopath Assoc"},{"issue":"1","key":"10.4065\/84.8.702_bib14","first-page":"43","article-title":"The effect of dimethylsulfoxide on the permeability of the urinary bladder","volume":"6","author":"Borzelleca","year":"1968","journal-title":"Invest Urol"},{"issue":"3, pt 1","key":"10.4065\/84.8.702_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"issue":"6","key":"10.4065\/84.8.702_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11934-008-0077-1","article-title":"Botulinum toxin treatment for overactive bladder: risk of urinary retention","volume":"9","author":"Shaban","year":"2008","journal-title":"Curr Urol Rep"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961160520X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961160520X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T01:57:57Z","timestamp":1545098277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961160520X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S002561961160520X"],"URL":"https:\/\/doi.org\/10.4065\/84.8.702","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}